The University of Saskatchewan needed a compelling proposal to secure investment from the Canada First Research Excellence Fund (CFREF) for a water security research program.
Securing $83M in Government Funding for a Water Research Program
read more
Case Study
Evaluating SCPOR’s Impact on Patient-Oriented Research
The Saskatchewan Centre for Patient-Oriented Research (SCPOR) needed a third-party evaluation to understand its impact to date and optimize its strategy.
De-Risking Vaccine Development Through a Translational Research Public-Private Partnership
Facing the need to de-risk the development of new vaccines, a top-10 biopharma company required help articulating the strategic vision and business case for a translational research public-private partnership.
Ensuring the World is Ready for the World’s First HIV Vaccine
The Pox-Protein Public-Private Partnership (P5) is tackling an enduring and daunting challenge: developing the world’s first HIV vaccine and ensuring it achieves maximum public health impact.
Preparing Policymakers for the Next Generation of Personalized Medicine
A large biotech firm needed support in developing an evidence-based policy narrative in preparation for the launch of a CAR T-cell therapy for a rare form of cancer.
Creating a Global Policy Strategy to Support the Launch of an Innovative Influenza Antiviral for a Top-5 Pharma Company
The global headquarters of a top-5 pharmaceutical company needed to develop a global policy strategy to support the launch of a new treatment for influenza.
Balancing an Innovative Biotechnology Company’s Oncology Portfolio
A US-based biotech company required support to identify, evaluate and prioritize novel immunotherapies and targeted oncology drug candidates to supplement its clinical pipeline.
Advancing a Collaborative Vision and Strategy for the Global HIV Vaccine Enterprise
The International AIDS Society (IAS) required support to develop a 5-year strategy for the Global HIV Vaccine Enterprise (the Enterprise)—a long-time convenor and facilitator for the HIV vaccine R&D field.
Assessing a Therapy’s Potential Use and Adoption in Treatment Resistant Depression
To support a mid-stage clinical development program, a top-5 pharmaceutical company engaged Shift Health to obtain an understanding of physicians’ decision-making process with alternative therapies.